Estadístiques de Expert consensus on the management of adverse events of Lorlatinib in the treatment of ALK+ advanced non-small cell lung cancer
Visites totals
| views | |
|---|---|
| Expert consensus on the management of adverse events of Lorlatinib in the treatment of ALK+ advanced non-small cell lung cancer | 8 |
Visites totals per mes
| views | |
|---|---|
| April 2025 | 3 |
| May 2025 | 1 |
| June 2025 | 1 |
| July 2025 | 0 |
| August 2025 | 3 |
| September 2025 | 0 |
| October 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| Arriola_cdi_expe.pdf | 83 |